Recently, Nan et al. employed a novel marker, LOX-1, to analyze G-MDSCs in HCC patients and determined that LOX-1+CD15+ cells were significantly increased both in the peripheral blood and in tumor tissue of patients compared with healthy controls and were positively related to OS. This evidence concerns the gene FUT4 and neoplasm.